Pharmaceuticals and Nanotech Connect

Pharmaceuticals & Nanotech Connect is a peer-reviewed, open-access journal that provides a platform for publishing advanced research at the interface of pharmaceutical sciences and nanotechnology. The journal highlights innovative studies that enhance drug development, delivery, efficacy, and safety, while showcasing nanoscale technologies that drive future breakthroughs in healthcare and therapeutic innovation. This open-access journal follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0).

Volumes 1

Articles 0

Volume: 1, 2026

Submit Article Join Our Editorial Board Become a Reviewer

Download Flyer

: Pharmaceuticals and Nanotech Connect Home

Aims and Scope

Editorial Board

Author's Instructions

Special Issue Guidelines

News

Open Access Policy:
All articles published in the journal “Pharmaceuticals and Nanotech Connect” are made accessible through an open-access model, released under the CCBY license. This license facilitates the unrestricted dissemination of articles, encouraging widespread sharing and utilization of valuable research contributions.

Publication Charges:
There will be no article processing charges (APCs) for submissions made by December 2026, and all articles will be available as Open Access.

Subject Categories:
Pharmaceuticals, Nanotechnology, Nanopharmaceuticals

Article Template:
You are encouraged to use the template to format your article according to our guidelines. However, this is not mandatory, as our layout team will ensure all necessary adjustments are made after acceptance and prior to final publication.

Download Template

Target Audience:
Pharmaceuticals and Nanotech Connect is tailored for researchers, scientists, clinicians, engineers, and industry professionals engaged in advancing innovations in pharmaceutical sciences and nanotechnology, with applications ranging from drug discovery and delivery to materials and medical technologies.

Ethics Statement:
All articles published by Pharmaceuticals and Nanotech Connect adhere strictly to the ethical guidelines suggested by the Committee on Publication Ethics (COPE). We execute a stringent peer-review procedure that meticulously assesses the originality, quality, and precision of the research we disseminate. We employ advanced tools to scrutinize the legitimacy of submitted content and maintain a firm zero-tolerance stance toward instances of plagiarism, data manipulation, or inappropriate authorship.
For further details, please review our comprehensive Publication Ethics and Integrity Guidelines.

Recent Updates

All Updates

New Journal Announcement: Pharmaceuticals & Nanotech Connect

2025-10-10